Doliver Capital Advisors »

Corbus Pharmaceuticals Hldgs shares owned by Doliver Capital Advisors

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Doliver Capital Advisors from 13F filings

Historical chart of Doliver Capital Advisors investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Doliver Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Doliver Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-09-30 $518k 76k 6.82

More positions owned by Doliver Capital Advisors

Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Us Gwt (IUSG)
Tidal Trust Ii Dga Co Pl Ab Etf (HF)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Eaton Corp SHS (ETN)
Micron Technology (MU)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Doliver Capital Advisors

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
OrbiMed Advisors
BlackRock
Standard Life Aberdeen
Diadema Partners
Vanguard Capital Management
Jones Hill Capital
Prosight Management
Caption Management
Susquehanna International
ADAR1 Capital Management
Stonepine Capital Management
Geode Capital Management
Citadel Advisors
Dimensional Fund Advisors

View all funds holding Corbus Pharmaceuticals Hldgs